INO: Inovio Pharmaceuticals Inc

INO News

• 14:00 INO Stock Soars as FDA Backs Rolling BLA for Rare Lung Disease Drug
• 17:04 Inovio: Back On Track With INO-3107 BLA For RRP Before End Of 2025
• 15:04 PGEN Stock Surges 144% in August on FDA Nod for Rare Lung Disease Drug
• 10:39 Jefferies lowers Inovio stock price target to $1.80 from $2.00
• 09:14 JMP analyst reiterates Market Outperform rating on Inovio stock
• 07:26 Inovio Pharmaceuticals, Inc. (INO) Q2 2025 Earnings Call Transcript
• 22:55 Agenus (AGEN) Reports Q2 Loss, Beats Revenue Estimates
• 13:10 3 Biotech Stocks Likely to Outpace Q2 Earnings Estimates
• 14:00 Earnings Preview: Dianthus Therapeutics, Inc. (DNTH) Q2 Earnings Expected to Decline
• 14:00 Inovio Pharmaceuticals (INO) Expected to Beat Earnings Estimates: Should You Buy?
• 14:13 This Wingstop Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday - C3.ai (NYSE:AI), Freeport-McMoRan (NYSE:FCX)
• 09:27 Piper Sandler initiates Inovio Pharmaceuticals stock with Overweight rating
• 16:31 Crude Oil Down 1%; Tripadvisor Shares Jump - Inovio Pharmaceuticals (NASDAQ:INO), Franklin Covey (NYSE:FC)
• 14:08 Dow Jumps Over 200 Points; US Nonfarm Payrolls Beat Estimates - Global Interactive (NASDAQ:GITS), Inovio Pharmaceuticals (NASDAQ:INO)
• 11:37 Inovio prices $25 million public offering of common stock and warrants
• 09:44 Why Datadog Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket - Aebi Schmidt Holding (NASDAQ:AEBI), ReAlpha Tech (NASDAQ:AIRE)
• 20:33 INOVIO announces proposed public offering of common stock
• 20:23 Inovio Pharmaceuticals stock plunges after announcing public offering
• 08:57 JMP maintains Cidara stock with $47 target, upbeat on flu drug
• 21:26 Inovio shareholders approve board nominees and proposals
• 11:54 Oppenheimer cuts Inovio stock price target to $13
• 02:15 Inovio Pharmaceuticals (INO) Q4 2024 Earnings Call Transcript
• 00:49 Inovio Pharmaceuticals, Inc. 2024 Q4 - Results - Earnings Call Presentation (NASDAQ:INO)
• 00:48 Inovio Pharmaceuticals, Inc. (INO) Q4 2024 Earnings Call Transcript